Teva Pharmaceutical's Biggest Blockbuster Might Be To Treat Huntington's

By: via Benzinga
Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) shares are up 5 percent year-to-date, while hitting a high of $72 on July ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.